FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945681730> ?p ?o ?g. }

• W2945681730 endingPage "488" @default.
• W2945681730 startingPage "480" @default.
• W2945681730 abstract "Abstract Purpose Throughout the world, illicit drug use continues to pose a significant risk to public health. The opioid crisis in North America, the diversion of the prescription drug tramadol throughout Africa, and the increasing supply of methamphetamines in East and South Asia all contribute to increasing risks to individual and societal health. Furthermore, the violation of human rights in efforts to enforce prohibitionist values poses significant threats to many individuals worldwide. With these evolving situations, it is imperative that researchers direct their attention to the various populations of illicit drug users. However, the inclusion of illicit drug users, often considered a vulnerable population, as participants in research studies presents several increased risks that must be addressed in study protocols. Researchers are required to provide “additional safeguards” to all study protocols involving illicit drug users, but there is often substantial variability and inconsistency in how these safeguards are applied. Additional safeguards can be timely, costly, and unduly burdensome for researchers, ethical review boards, and research participants. Approach Through synthesis of the current literature, this article addresses the barriers to studying illicit drug users and the methods researchers can utilize to minimize risk. A case study is provided to illustrate the high level of scrutiny of study protocols involving the participation of illicit drug users and the effect of such scrutiny on recruitment of participants. The article concludes with a discussion of the effects of the current political climate on the recruitment of illicit drug users in research. Conclusions Individuals who participate in criminal or illegal behaviors such as illicit drug use, prostitution, illegal entry into a country, and human trafficking are susceptible to multiple physical, mental, and social health risks, as well as criminal prosecution. The importance of research on the health of marginalized populations cannot be overstated. This work must continue, and at the same time, we must continue to protect these individuals to the best of our ability through diligent attention to sound research methods. Clinical Relevance The use of illicit drugs continues to pose a substantial threat to global health. Individuals who use illicit drugs are susceptible to multiple physical, mental, and social health risks, as well as criminal prosecution. It is imperative that researchers study these vulnerable populations in order to develop interventions to minimize individual and societal harm. There are several barriers to the study of illicit drug users that must be addressed through rigorous methodology and the addition of safeguards." @default.
• W2945681730 created "2019-05-29" @default.
• W2945681730 creator A5015781368 @default.
• W2945681730 creator A5060833367 @default.
• W2945681730 creator A5086179141 @default.
• W2945681730 date "2019-05-20" @default.
• W2945681730 modified "2023-09-27" @default.
• W2945681730 title "Challenges to Studying Illicit Drug Users" @default.
• W2945681730 cites W1560949317 @default.
• W2945681730 cites W1979673801 @default.
• W2945681730 cites W1984266274 @default.
• W2945681730 cites W1991639653 @default.
• W2945681730 cites W1997431796 @default.
• W2945681730 cites W2010282724 @default.
• W2945681730 cites W2012130878 @default.
• W2945681730 cites W2013278979 @default.
• W2945681730 cites W2015965189 @default.
• W2945681730 cites W2040402415 @default.
• W2945681730 cites W2045625729 @default.
• W2945681730 cites W2059539561 @default.
• W2945681730 cites W2070990142 @default.
• W2945681730 cites W2090243781 @default.
• W2945681730 cites W2092607511 @default.
• W2945681730 cites W2097742040 @default.
• W2945681730 cites W2103690876 @default.
• W2945681730 cites W2115797877 @default.
• W2945681730 cites W2129301611 @default.
• W2945681730 cites W2143929325 @default.
• W2945681730 cites W2156812612 @default.
• W2945681730 cites W2165584474 @default.
• W2945681730 cites W2332005422 @default.
• W2945681730 cites W2343018085 @default.
• W2945681730 cites W2414572832 @default.
• W2945681730 cites W2499590469 @default.
• W2945681730 cites W2765348434 @default.
• W2945681730 cites W318657242 @default.
• W2945681730 cites W4212983131 @default.
• W2945681730 cites W4230532328 @default.
• W2945681730 cites W4252295371 @default.
• W2945681730 cites W4253713631 @default.
• W2945681730 doi "https://doi.org/10.1111/jnu.12486" @default.
• W2945681730 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6671678" @default.
• W2945681730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31106524" @default.
• W2945681730 hasPublicationYear "2019" @default.
• W2945681730 type Work @default.
• W2945681730 sameAs 2945681730 @default.
• W2945681730 citedByCount "13" @default.
• W2945681730 countsByYear W29456817302020 @default.
• W2945681730 countsByYear W29456817302021 @default.
• W2945681730 countsByYear W29456817302022 @default.
• W2945681730 countsByYear W29456817302023 @default.
• W2945681730 crossrefType "journal-article" @default.
• W2945681730 hasAuthorship W2945681730A5015781368 @default.
• W2945681730 hasAuthorship W2945681730A5060833367 @default.
• W2945681730 hasAuthorship W2945681730A5086179141 @default.
• W2945681730 hasBestOaLocation W29456817301 @default.
• W2945681730 hasConcept C108827166 @default.
• W2945681730 hasConcept C118552586 @default.
• W2945681730 hasConcept C138816342 @default.
• W2945681730 hasConcept C144133560 @default.
• W2945681730 hasConcept C15744967 @default.
• W2945681730 hasConcept C159110408 @default.
• W2945681730 hasConcept C17744445 @default.
• W2945681730 hasConcept C199539241 @default.
• W2945681730 hasConcept C2776050585 @default.
• W2945681730 hasConcept C2777329821 @default.
• W2945681730 hasConcept C2780035454 @default.
• W2945681730 hasConcept C2908647359 @default.
• W2945681730 hasConcept C3020689752 @default.
• W2945681730 hasConcept C39549134 @default.
• W2945681730 hasConcept C41008148 @default.
• W2945681730 hasConcept C71924100 @default.
• W2945681730 hasConcept C73484699 @default.
• W2945681730 hasConcept C99454951 @default.
• W2945681730 hasConceptScore W2945681730C108827166 @default.
• W2945681730 hasConceptScore W2945681730C118552586 @default.
• W2945681730 hasConceptScore W2945681730C138816342 @default.
• W2945681730 hasConceptScore W2945681730C144133560 @default.
• W2945681730 hasConceptScore W2945681730C15744967 @default.
• W2945681730 hasConceptScore W2945681730C159110408 @default.
• W2945681730 hasConceptScore W2945681730C17744445 @default.
• W2945681730 hasConceptScore W2945681730C199539241 @default.
• W2945681730 hasConceptScore W2945681730C2776050585 @default.
• W2945681730 hasConceptScore W2945681730C2777329821 @default.
• W2945681730 hasConceptScore W2945681730C2780035454 @default.
• W2945681730 hasConceptScore W2945681730C2908647359 @default.
• W2945681730 hasConceptScore W2945681730C3020689752 @default.
• W2945681730 hasConceptScore W2945681730C39549134 @default.
• W2945681730 hasConceptScore W2945681730C41008148 @default.
• W2945681730 hasConceptScore W2945681730C71924100 @default.
• W2945681730 hasConceptScore W2945681730C73484699 @default.
• W2945681730 hasConceptScore W2945681730C99454951 @default.
• W2945681730 hasIssue "4" @default.
• W2945681730 hasLocation W29456817301 @default.
• W2945681730 hasLocation W29456817302 @default.
• W2945681730 hasLocation W29456817303 @default.
• W2945681730 hasLocation W29456817304 @default.
• W2945681730 hasLocation W29456817305 @default.

• next